Kim Kopenhaver Doheny

Title: Kim Kopenhaver Doheny: Innovator in Neonatal Care

Introduction

Kim Kopenhaver Doheny is a notable inventor based in Harrisburg, PA (US). She has made significant contributions to the field of neonatal care, particularly in the prediction and treatment of necrotizing enterocolitis in preterm infants. Her innovative approach combines advanced analysis techniques to improve outcomes for vulnerable newborns.

Latest Patents

Kim Kopenhaver Doheny holds a patent titled "Methods for predicting and treating necrotizing enterocolitis in neonates." This patent presents embodiments that provide early prediction of the development of necrotizing enterocolitis through the analysis of the high-frequency component of heart rate variability, optionally alongside respiration rate analysis. The methods of treatment following prediction are also reported, showcasing her commitment to enhancing neonatal health.

Career Highlights

Doheny is affiliated with the Penn State Research Foundation, where she continues to work on innovative solutions in healthcare. Her dedication to research and development has positioned her as a key figure in her field, contributing to advancements that can save lives.

Collaborations

One of her notable collaborators is Charles E. Palmer, with whom she has worked closely on various projects aimed at improving neonatal care.

Conclusion

Kim Kopenhaver Doheny's work exemplifies the impact of innovation in healthcare, particularly for the most vulnerable patients. Her contributions through her patent and ongoing research are paving the way for better predictive and treatment methods in neonatal care.